Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study

Diabetes Care

Volumn 27, Issue 8, 2004, Pages 1954-1961

  Wackers, Frans J Th ^a   Young, Lawrence H ^a   Inzucchi, Silvio E ^a   Chyun, Deborah A ^b   Davey, Janice A ^a   Barrett, Eugene J ^c   Taillefer, Raymond ^d   Wittlin, Steven D ^e   Heller, Gary V ^f   Filipchuk, Neil ^g   Engel, Samuel ^h   Ratner, Robert E ⁱ   Iskandrian, Ami E ^j  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f HARTFORD HOSPITAL   (United States)

^g Cardiology Consultants   (Canada)

^h Soundview Research Associates   (United States)

ⁱ MEDSTAR RESEARCH INSTITUTE   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; FEMALE; GENDER; HEART DILATATION; HEART MUSCLE PERFUSION; HEART VENTRICLE FUNCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL SOCIETY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SILENT MYOCARDIAL ISCHEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT DEPRESSION; SYMPTOM; THROMBOSIS; VALSALVA MANEUVER;

EID: 3342948360     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.8.1954     Document Type: Article

References (37)

1. Young LH, Chyun DA: Heart disease in patients with diabetes. In Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice. 6th ed, Porte DJ, Baron A, Sherwin RS, Eds. New York, McGraw-Hill, 2002, p. 823-844
2. BARI Investigators: Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96:1761-1769, 1997
3. BARI Investigators: Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35:1122-1129, 2000
4. American Diabetes Association: Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care 26 (Suppl. 1):S83-S86, 2003
5. American Diabetes Association: Aspirin therapy in diabetes (Position Statement). Diabetes Care 26 (Suppl. 1):S87-S88, 2003
6. American Diabetes Association: Treatment of hypertension in adults with diabetes (Position Statement). Diabetes Care 26 (Suppl. 1):S80-S82, 2003
7. American Heart Association: Prevention Conference VI: diabetes and cardiovascular disease. Circulation 105:2231-2239, 2002
8. American Diabetes Association: Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21:1551-1559, 1998
9. Milan Study on Atherosclerosis and Diabetes Group: Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 79:134-139, 1997
10. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V: Silent myocardial ischemia in patients with diabetes. Diabetes Care 22:1396-1400, 1999
11. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, De Amici E, Geroldi D, Fratino P: Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients. Diabetes Care 25:1418-1424, 2002
12. De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR: Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 90:827-832, 2002
13. Rose G, McCartney P, Reid DD: Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Med 31:42-48, 1977
14. Ewing DJ, Borsey DQ, Bellavere F, Clarke BF: Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 21:18-24, 1981
15. Risk M, Bril V, Broadbridge C, Cohen A: Heart rate variability measurement in diabetic neuropathy: review of methods. Diabetes Technol Ther 3:63-76, 2001
16. DePuey EG, Garcia EV: Updated imaging guidelines for nuclear cardiology procedures: part 1. J Nucl Cardiol 8:G1-G58, 2001
17. Liu YH, Sinusas AJ, DeMan P, Zaret BL, Wackers FJ: Quantification of SPECT myocardial perfusion images: methodology and validation of the Yale-CG method. J Nucl Cardiol 2:190-204, 1999
18. Lam PT, Wackers FJT, Liu YH: Validation of a new method for quantification of left ventricular function from ECG-gated SPECT (Abstract). J Nucl Med 42:93P, 2001
19. Iskandrian AE: Risk assessment of stable patients (Panel II): proceedings of the 4th Invitational Wintergreen Conference Wintergreen panel summaries. J Nucl Cardiol 6:93-155, 1999
20. SAS Institute: SAS Version 6.12. Cary, NC, SAS Institute, 1998
21. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, Borges-Neto S, Berman DS, Waters DD, Heller GV: Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 105:32-40, 2002
22. Kang X, Berman DS, Lewin H, Miranda R, Erel J, Friedman JD, Amanullah AM: Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 137:949-957, 1999
23. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW: Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 67:1073-1078, 1991
24. Vinik AI, Mitchell BD, Maser RE, Freeman R: Diabetic autonomic neuropathy (Technical Review). Diabetes Care 26:1553-1579, 2003
25. , Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attati JR: Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24:339-343, 2001
26. Valensi P, Paries J, Attali JR, the French Group for Research and Study of Diabetic Neuropathy: Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and the microangiopathic complications: the French Multicenter study. Metabolism 52:815-820, 2003
27. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D: Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study, 1987-1998. Circulation 107:2190-2195, 2003
28. Lee K, Jang H, Kim Y, Lee EJ, Choe YS, Choi Y, Lee MG, Lee SH, Kim B: Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease. Am J Cardiol 92:1458-1461, 2003
29. Kannel WB, Wilson PWF: Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 155:57-61, 1995
30. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET: Adverse effects of diabetes on multiple cardiovascular risk factors in women: the Strong Heart Study. Diabetes Care 21:1258-1265, 1998
31. Klodas E, Miller TD, Christian TF, Hodge DO, Gibbons RJ: Prognostic significance of ischemic changes during vasodilator stress testing in patients with normal SPECT images. J Nucl Cardiol 10:4-8, 2003
32. Abbott BG, Afshar M, Berger AK, Wackers FJT: Prognostic significance of ischemic changes during adenosine infusion in patients with normal myocardial perfusion imaging. J Nucl Cardiol 10:9-16, 2003
33. Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, Hachamovitch R, Shaw LJ: Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 138:1025-1032, 1999
34. Nesto RW: Screening for asymptomatic coronary artery disease in diabetes (Editorial). Diabetes Care 22:1393-1395, 1999
35. Berman DS, Kiat H, Friedman JD, Diamond G: Clinical applications for exercise nuclear cardiology studies in the era of healthcare reform. Am J Cardiol 75:3D-13D, 1995
36. Maser RE, Vinik AI, Mitchell BD, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care 26:1895-1901, 2003
37. Gerritsen J, Heine RJ, Dekker JM, Bouter LM, TenVoorde BJ, Heethaar RM, Kostense PJ, Stehouwer CDA: Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease. Diabetes Care 24:1793-1798, 2001